We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Illumina Inc | NASDAQ:ILMN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-5.71 | -4.61% | 118.28 | 14.50 | 134.52 | 127.745 | 117.67 | 127.08 | 2,987,106 | 05:00:10 |
Genetic-sequencing company Illumina Inc. posted a 34% decline in profit for its first quarter amid climbing expenses.
Expenses rose 39% to $276 million, with research and development expenses climbing to $124 million from $91.8 million in the prior-year period.
On the heels of the latest results, the San Diego maker of gene-sequencing machines lowered its annual guidance for adjusted earnings on a per-share basis to $3.35 to $3.45, from a previous estimate of $3.55 to $3.65. Analysts surveyed by Thomson Reuters expected $3.48 a share.
For the current quarter, Illumina projects adjusted earnings of 72 cents to 74 cents a share on revenue of $590 million to $595 million. Analysts forecast 84 cents and $611 million, respectively.
Shares of the company slipped 3.7% to $128.67 in after-hours trading Tuesday.
In all, for the quarter ended April 3, Illumina earned $89.6 million, or 60 cents a share, compared with $136.7 million, or 92 cents a share, a year earlier. Earnings excluding items were 71 cents a share, down from 91 cents.
Revenue rose 6% to $572 million.
Analysts surveyed by Thomson Reuters expected earnings of 74 cents a share on revenue of $593 million.
Write to Ezequiel Minaya at ezequiel.minaya@wsj.com
(END) Dow Jones Newswires
May 03, 2016 17:45 ET (21:45 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Illumina Chart |
1 Month Illumina Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions